Lipitor

Atorvastatin, the active ingredient in Lipitor, is a HMG‑CoA reductase inhibitor presented as a tablet for oral use. It treats hypercholesterolemia, mixed dyslipidemia and helps prevent cardiovascular events in adult patients. GNH USA supplies Lipitor as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lipitor is a statin that lowers abnormal lipid levels and reduces cardiovascular risk. - Hypercholesterolemia: reduces LDL‑cholesterol to target goals. - Mixed dyslipidemia: lowers total cholesterol, LDL‑C and triglycerides while modestly raising HDL‑C. - Prevention of cardiovascular events: decreases the risk of myocardial infarction, stroke and revascularisation in at‑risk patients.

Common Side Effects: - Headache: mild to moderate intensity. - Myalgia: muscle aches without weakness. - Abdominal pain: occasional discomfort. - Nausea: transient gastrointestinal upset.

Serious or Rare Side Effects: - Rhabdomyolysis: severe muscle breakdown requiring urgent care. - Elevated liver enzymes: indicates possible hepatic injury. - Severe allergic reaction: rash, swelling, or anaphylaxis. - Myopathy: muscle weakness with elevated creatine kinase.

Before starting Lipitor, clinicians should evaluate liver function and consider patient-specific factors. - Assess liver function: obtain baseline transaminases. - Monitor lipid profile: check levels periodically to gauge efficacy. - Avoid use in pregnancy: contraindicated due to fetal risk. - Adjust dose in renal impairment: consider lower doses for severe dysfunction. - Review concomitant medications: watch for drugs that affect statin metabolism. - Store at room temperature: keep in the original pack, protect from moisture.

Lipitor may interact with several medicines that alter its plasma concentration. Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., clarithromycin, itraconazole): increase atorvastatin exposure. - Gemfibrozil: heightened risk of myopathy. - Cyclosporine: elevates statin levels, raising toxicity risk. Moderate Interactions (Monitor Closely): - Certain antibiotics (e.g., erythromycin, fluconazole): may modestly raise concentrations. - Warfarin: potential enhancement of anticoagulant effect. - Niacin: may increase liver enzyme abnormalities.